Sessions

Orexin agonist improves inflammation-induced immobility

[Speaker] Shuntaro Uchida:1
[Co-author] Yoko T Irukayama:1, Yasuhiro Ogawa:1, Takuto Yamaguchi:1, Yukiko Ishikawa:1, Shingo Soya:1, Tsuyoshi Saito:1, Hiroshi Nagase:1, Masashi Yanagisawa:1, Takeshi Sakurai:1
1:International Institute for Integrative Sleep Medicine, University of Tsukuba, Japan

Comparison of preventive and therapeutic effect on cardio-cerebral ischemic disease between Salvianolic acids and Aspirin

[Speaker] Juntian Zhang:1
[Co-author] Guanhua Du:1, Shifeng Chu:1
1:Institute of Materia Medica, Chinese Academy of Medical Sciences, China

Semi-synthetic sapogenin exerts neuroprotective effects by skewing the brain ischemia reperfusion transcriptome towards inflammatory resolution

[Speaker] García-Pupo L:1
[Co-author] Sánchez JR:1, Ratman D:2, Pérez-Novo C:3, Declerck K:3, De Bosscher K:2, Markakis Mn:4, Beemster G:4, Zaldo A:5, Figueredo Y Nuñez:1, Delgado-Hernández R:1, Vanden Berghe W:3
1:Centro de Investigación y Desarrollo de Medicamentos (CIDEM), BioCubaFarma, Cuba, 2:Receptor Research Laboratories, Nuclear Receptor Lab, Medical Biotechnology Center, VIB, Department of Biochemistry, Ghent University, Belgium, 3:Proteinscience, Proteomics and Epigenetic Signaling, Department of Biomedical Sciences, University of Antwerp, Belgium, 4:Integrated Molecular Plant Physiology Research (IMPRES), Department of Biology, University of Antwerp, Campus Groenenborger, Belgium, 5:Centro de Estudios de Productos Naturales, Facultad de Química, Universidad de la Habana, Zapata s/n entre G y Carlitos Aguirre, Vedado, Cuba

Adenosine A3 receptor, as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury

[Speaker] Salvatore Cuzzocrea:1
[Co-author] Michela Campolo:1, Emanuela Esposito:1, Giovanna Casili:1, Timothy Doyle:2, Daniela Salvemini:2
1:Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Italy, 2:Department of Pharmacology and Physiology Saint Louis University, MO, USA

Anti-HMGB1 mAb therapy for intracerebral hemorrhage-induced brain injury in rats

[Speaker] Dengli Wang:1
[Co-author] Keyue Liu:1, Hidenori Wake:1, Kiyoshi Teshigawara:1, Shuji Mori:2, Masahiro Nishibori:1
1:Department of Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Japan, 2:School of Pharmacy, Shujitsu University, Japan

Advanced Search